Welcome back to Health Unlocked: The Power of Salutogenesis, where we explore cutting-edge ideas shaping the future of healthcare. In this episode, Jasen Petersen discusses how Ion Biotechnology is pivoting its US market entry strategy amidst shifting crypto and DeSci (Decentralized Science) market conditions.
Instead of pursuing the costly and complex 510k regulatory pathway immediately, he reveals a new plan centered on launching the Ion Gel as a Class 1 medical device or even as a cosmetic product, leveraging the terrain support concept. This approach not only allows faster access to the US market and clinical data generation but also provides a foundation for stronger future regulatory submissions. Along the way, he covers the importance of academic publication, community involvement via token funding, and maintaining transparency as the project evolves.
Tune in to get a real-time look at how innovation, regulation, and community engagement intersect in biotech.
Timestamps:
00:00 Finding a cost-effective FDA strategy
06:17 FDA classification and product function
09:33 Understanding product claims and regulations
12:51 Preventing diabetic foot ulcers
17:15 Overview of the research papers
21:30 Launching token before DAO
24:50 Presenting research and generating interest
27:22 FDA reclassification and strategy
31:37 Using real-world data for strategy
35:26 Navigating FDA classification challenges
38:09 Connecting with Jason and updates
39:50 Wrapping up the episode
Navigating Market Entry: Key Insights from Health Unlock the Power of Salutogenesis with Jasen Petersen
Shifting Strategies in a Challenging Market
In a recent episode of "Health Unlock the Power of Salutogenesis," host Jasen Petersen discussed the strategic pivots necessary for healthcare innovators in today’s unpredictable environment. As Jasen Petersen explained, the original plan centered around pursuing a 510(k) pathway for regulatory approval. However, following a downturn in the broader crypto market, which also affected the decentralized science (DeSci) funding ecosystem, the team was compelled to reconsider their approach.
The conversation highlighted that market forces, such as drops in token valuations and reduced community funding capacity, have a direct impact on timelines for healthcare product development. For those building in the intersection of healthcare and emerging technology, adaptability is crucial. Instead of pausing progress, Jasen Petersen described how a new entry strategy might actually yield better long-term results.
Leveraging Class 1 Medical Device Status
One of the episode’s standout insights came when Jasen Petersen elaborated on how their ion gel product could enter the US market as a Class 1 medical device. Unlike Class 2 devices, which require lengthy and expensive reviews, Class 1 devices only require an establishment registration with the FDA, product listing, and compliance with basic quality and labeling requirements. Most importantly, these devices can be marketed immediately, provided no therapeutic or disease-specific claims are made.
This kind of positioning emphasizes terrain support for metabolically stressed tissue, shifting the language to mirror how supplements are introduced to consumers. By focusing on enhancing the body’s local tissue environment, the product sidesteps the need for making direct claims about treating specific conditions. Jasen Petersen illustrated with the example of diabetic foot ulcer prevention, clarifying that “supporting local tissue environment” provides a compliant and scientifically grounded way to reach those who could benefit most.
Building Evidence and Community Engagement
Throughout the episode, the speakers stressed the importance of building a robust evidence base alongside early market entry. Jasen Petersen revealed their acceptance of an abstract at the Symposium on Advanced Wound Care, where a cohort study with 71 patients yielded promising wound healing results. Instead of direct claims, the publication strategy involves sequentially building scientific validation, starting with hypotheses and real-world data, and then expanding to applications beyond wound healing.
This approach not only strengthens future regulatory submissions but also invites collaboration and scrutiny from both academic and clinical partners. Transparency remains a priority, with each step from market adaptation to evidence dissemination shared openly with the community.
Creating Impact While Preparing for Full Regulatory Approval
Entering the market as a Class 1 medical device is not considered a detour but a calculated step that makes subsequent regulatory filings, such as the 510(k), more compelling. Jasen Petersen explained at that, within eighteen to twenty-four months, the team expects to gather substantial US clinical data, develop practitioner relationships, refine quality management systems, and fine-tune product messaging based on market feedback. This foundation will render the eventual Class 2 submission more robust, potentially streamlining both approval and commercialization.
Interestingly, the team is prepared for the possibility that their unique positioning might prompt regulatory reclassification or competitive challenges. If competitors request the FDA to reconsider the product’s risk category, it could accelerate the desired upgrade to Class 2 status, allowing more direct claims related to disease treatment.
How Listeners Can Get Involved
As Jasen Petersen emphasized, there are multiple ways for supporters to participate in the journey. Practitioners can join early evidence-gathering efforts, investors can fund the publication and education mission via the project’s token, and researchers are invited to collaborate on expanding the scientific framework. For others, simply sharing the episode and spreading awareness is a valuable contribution.
To stay updated or get involved, listeners can reach out through the show’s website or connect with the Jasen on LinkedIn. This open-door approach exemplifies the commitment to building in public, welcoming scrutiny, and adapting to both challenges and opportunities as they arise.
Stay tuned to Health Unlock: The Power of Salutogenesis for candid updates as the project navigates the complex but promising path to market and impact.
“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”
Show Website - https://powerofsalutogenesis.com/
Ionic Alliance Foundation Website - https://iaf.care/
Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/
TopHealth Media Website - https://tophealth.care/